Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance
Citations Over TimeTop 1% of 2015 papers
Abstract
Adiponectin plays a key role in the regulation of the whole-body energy homeostasis by modulating glucose and lipid metabolism. Although obesity-induced reduction of adiponectin expression is primarily ascribed to a transcriptional regulation failure, the underlying mechanisms are largely undefined. Here we show that DNA hypermethylation of a particular region of the adiponectin promoter suppresses adiponectin expression through epigenetic control and, in turn, exacerbates metabolic diseases in obesity. Obesity-induced, pro-inflammatory cytokines promote DNMT1 expression and its enzymatic activity. Activated DNMT1 selectively methylates and stimulates compact chromatin structure in the adiponectin promoter, impeding adiponectin expression. Suppressing DNMT1 activity with a DNMT inhibitor resulted in the amelioration of obesity-induced glucose intolerance and insulin resistance in an adiponectin-dependent manner. These findings suggest a critical role of adiponectin gene epigenetic control by DNMT1 in governing energy homeostasis, implying that modulating DNMT1 activity represents a new strategy for the treatment of obesity-related diseases.
Related Papers
- → High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men(2007)72 cited
- → A mathematical model of adiponectin resistance(2020)8 cited
- → Disparity in circulating adiponectin multimers between term and preterm infants(2009)5 cited
- → Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis(2012)1 cited
- → Adiponectin(2010)